Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
Plos One|September 24, 2013
Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularizationChun-hong Xia, Eric Lu, Jing Zeng, et al.Medicine and Science in Sports and Exercise|February 7, 2014
Skeletal response to resistance and impact training in prostate cancer survivorsKerri M Winters-Stone, Jessica C Dobek, Jill A Bennett, et al.BJU International|June 8, 2007
Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acidChristopher W Ryan, Dezheng Huo, Kathryn Bylow, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancerWalter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.The Journal of Urology|September 23, 2003
Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancerWalter M Stadler, Dezheng Huo, Christopher George, et al.Obstetrical & Gynecological Survey|December 28, 2017
The Safety of Low-Molecular-Weight Heparin During and After PregnancyEric Lu, Joseph J Shatzel, Jennifer Salati, et al.Elife|September 1, 2022
Ait1 regulates TORC1 signaling and localization in budding yeastRyan L Wallace, Eric Lu, Xiangxia Luo, et al.Cancer Medicine|December 24, 2018
Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adultsBrittany Wippel, Kenneth R Gundle, Theresa Dang, et al.Clinical Genitourinary Cancer|June 10, 2022
A Phase II, Single-arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell CarcinomaZizhen Feng, Brendan D Curti, David I Quinn, et al.Archives of Physical Medicine and Rehabilitation|September 8, 2014
Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trialKerri M Winters-Stone, Jessica C Dobek, Jill A Bennett, et al.Pageof 15